Abstract
Raised intracranial pressure (ICP) is a major contributor to the mortality of many conditions encountered in a neurologic intensive care unit. Achieving a sustained reduction in ICP in patients with intracranial hypertension remains a challenge. Treatment with hyperosmolar agents is one of the few options that are available, and mannitol is currently the most commonly used agent. However, hypertonic saline solutions have recently emerged as a potentially safer and more efficacious alternative to mannitol.
Original language | English (US) |
---|---|
Pages (from-to) | 524-530 |
Number of pages | 7 |
Journal | Current neurology and neuroscience reports |
Volume | 3 |
Issue number | 6 |
DOIs | |
State | Published - Nov 2003 |
Externally published | Yes |
ASJC Scopus subject areas
- Neuroscience(all)
- Clinical Neurology